基于改进2DCNN的高光谱遥感图像处理研究

针对传统遥感图像处理中的时间成本和人工成本高、效率低等问题,以提高遥感高光谱图像分类中的处理速度、精度,降低参数量为目标,提出改进的2DCNN模型En-De-2CP-2DCNN.首先,使用1DCNN、2DCNN与3DCNN在Pavia University HSI数据集上分别进行分类实验,对比分析各自优缺点.其次,在保持较快的处理速度和不增加模型参数量的前提下,选择2DCNN为基础模型,参考SegNet的Encoder-Decoder结构,融入双卷积池化思想进行基础模型改进,同时优化学习策略.结果表明:En-De-2CP-2DCNN模型F1为99.96％,达到3DCNN的同等水平(99.36％),较改进前(97.28％)提高2.68个百分点;处理速度(5 s／epoch)和1DCNN位于同一量级,快于3DCNN(96 s／epoch);参数量(2.01 MB)较改进前降低了1.54 MB,虽高于3DCNN(316 KB),但远低于1DCNN(19.21 MB).En-De-2CP-2DCNN模型在处理速度和参数量方面的改进,有利于进一步实现移动端的轻量化部署.     

循环荷载作用下钢结构滞回性能的数值模型

提出了“塑性铰有限分布”的数值模型用以分析钢结构在循环荷载作用下的滞回性能。经与试验结果比较表明模型简单、易于实施，待进一步完善后，可直接用于对梁及压弯构件的模拟。     

TRIP带钢轧后冷却过程温度场的有限元模拟

应用有限元模拟仿真计算，对相变诱发塑性(TRIP)带钢在连轧机精轧后由850～890℃快冷至700℃，经几秒钟短暂空冷再第2次快速水冷至卷取温度400℃的冷却过程的温度进行了分析计算。分析结果得出，3mmTRIP带钢厚度方向的温差较小，而8mmTRIP带钢厚度方向温差明显增大。因此TRIP带钢在2次快速冷却后和卷取前应有适当的空冷时间以降低TRIP带钢卷取时表面和厚度方向中心处的温度差。     

Stable sodium metal anode enhanced by advanced electrolytes with SbF3 additive

The practical application of sodium metal batteries (SMBs) is hampered due to the inferior interfacial stability between Na metal and conventional electrolytes....     

助磨剂对粉石英超细磨矿的影响

研究了三乙醇胺对粉石英超细磨矿的影响及助磨作用机理，采用粒度分析、X-射线衍射分析、红外光谱分析等别代手段，定性描述了助磨剂的作用效果。并解释了助磨剂有效控制粉石英粉碎平衡、降低粉碎极限、延缓“团聚”形成的原因。     

Biomimetic Robust Starch Composite Films with Super-Hydrophobicity and Vivid Structural Colors

The starch composite films (SCFs) will be one of the best alternative packaging materials to petroleum based plastic films, which mitigates white pollution and energy consumption. However, weak mechanical stability, water resistance, and dyeability has hindered the application of SCFs. Herein, a bioinspired robust SCFs with super-hydrophobicity and excellent structural colors were prepared by fiber-reinforcement and assembling SiO₂/Polydimethylsiloxane (PDMS) amorphous arrays on the surface of SCFs. The properties of the designed SCFs were investigated by various methods including scanning electron microscope (SEM), Fourier transform infrared spectroscopy (FT-IR), X-ray diffraction (XRD), thermo-gravimetric analysis (TGA), a tensile test, contact angle (CA) test, and an optical test. The results showed that the obtained SCFs possessed a higher tensile strength (55.17 MPa) attributed to the formed abundant hydrogen bonds between the molecular chains of the starch, cellulose fiber, and polyvinyl alcohol. Benefiting from the nanostructure with rough surface which were modified by materials with low surface free energy, the contact angle and sliding angle of the film reached up to 154° and 2°, respectively. The colors which were produced by the constructive interference of the coherent scattered light could cover all of the visible regions by tuning the diameters of the SiO₂ nanoparticles. The strategy in the present study not only reinforces the mechanical strength and water resistance of SCFs but also provides an environmentally friendly way to color the them, which shows unprecedented application potential in packaging materials of the starch composite films.     

The Anticancer Activity Conferred by the Mud Crab Antimicrobial Peptide Scyreprocin through Apoptosis and Membrane Disruption

Scyreprocin is an antimicrobial peptide first identified in the mud crab Scylla paramamosain. Herein, we showed that its recombinant product (rScyreprocin) could significantly inhibit the growth of human lung cancer NCI-H460 cells (H460), but showed no cytotoxicity to human lung fibroblasts (HFL1). rScyreprocin was a membrane-active peptide that firstly induced the generation of reactive oxygen species (ROS) in H460, and led to endoplasmic reticulum stress and Ca²⁺ release, which resulted in mitochondrial dysfunction and subsequently activation of caspase-3 cascades, and ultimately led to apoptosis. The comprehensive results indicated that rScyreprocin exerted anticancer activity by disrupting cell membrane and inducing apoptosis. The in vivo efficacy test demonstrated that intratumoral injection of rScyreprocin significantly inhibited the growth of H460 xenografts, which was close to that of the cisplatin (inhibition rate: 69.94% vs. 80.76%). Therefore, rScyreprocin is expected to become a promising candidate for the treatment of lung cancer.